Vaxart, Inc. (NASDAQ:VXRT) – Analysts at B. Riley reduced their Q1 2021 EPS estimates for Vaxart in a research note issued to investors on Thursday, March 4th. B. Riley analyst M. Mamtani now anticipates that the biotechnology company will post earnings of ($0.08) per share for the quarter, down from their prior forecast of ($0.07). […]
